Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daohong Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
Yang, Y., Jn-Simon, N., He, Y., Sun, C., Zhang, P., Hu, W., Tian, T., Zeng, H., Basha, S., Huerta, A. S., Sun, L. Z., Yin, X. M., Hromas, R., Zheng, G., Pi, L. & Zhou, D., Mar 2025, In: Nature Aging. 5, 3, p. 386-400 15 p., 15691.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
Han, S., Tushoski-Alemán, G. W., Zhang, P., Zheng, G., Zhou, D., Huo, Z., Licht, J., George, T. J., Allegra, C., Trevino, J. G. & Hughes, S. J., Jan 2025, In: Neoplasia (United States). 59, 101070.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Senescent Cluster in Aged Human Hematopoietic Stem Cell Compartment as Target for Senotherapy
Poisa-Beiro, L., Landry, J. J. M., Yan, B., Kardorff, M., Eckstein, V., Villacorta, L., Krammer, P. H., Zaugg, J., Gavin, A. C., Benes, V., Zhou, D., Raffel, S. & Ho, A. D., Jan 2025, In: International journal of molecular sciences. 26, 2, 787.Research output: Contribution to journal › Article › peer-review
Open Access -
Sexual dimorphism in the mouse bone marrow niche regulates hematopoietic engraftment via sex-specific Kdm5c/Cxcl12 signaling
Cui, X., Hou, L., Yan, B., Liu, J., Zhang, C., Sui, P., Tong, S., Luchsinger, L., Mendelson, A., Zhou, D., Yang, F. C., Zhong, H. & Liang, Y., Mar 3 2025, In: Journal of Clinical Investigation. 135, 5, e182125.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy
Tomimatsu, N., Di Cristofaro, L. F. M., Kanji, S., Samentar, L., Jordan, B. R., Kittler, R., Habib, A. A., Espindola-Netto, J. M., Tchkonia, T., Kirkland, J. L., Burns, T. C., Sarkaria, J. N., Gilbert, A., Floyd, J. R., Hromas, R., Zhao, W., Zhou, D., Sung, P., Mukherjee, B. & Burma, S., Apr 9 2025, In: EMBO Molecular Medicine. 17, 4, p. 645-678 34 p., 109441.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Cryo-EM structure of the human BCDX2 complex
Rawal, Y. (Contributor), Jia, L. (Contributor), Meir, A. (Contributor), Zhou, S. (Contributor), Kaur, H. (Contributor), Ruben, E. A. (Contributor), Kwon, Y. (Contributor), Bernstein, K. A. (Contributor), Jasin, M. (Contributor), Taylor, A. B. (Contributor), Burma, S. (Contributor), Hromas, R. (Contributor), Mazin, A. V. (Contributor), Zhao, W. (Contributor), Zhou, D. (Contributor), Wasmuth, E. V. (Contributor), Greene, E. C. (Contributor), Sung, P. (Contributor) & Olsen, S. K. (Contributor), Protein Data Bank (PDB), Jun 21 2023
DOI: 10.2210/pdb8FAZ/pdb, https://www.wwpdb.org/pdb?id=pdb_00008faz
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset